Related Experiment Videos
[Sea-blue histiocyte syndrome]
R Etcheverry1, A Daiber, E Boris
1Departamento de Medicina, Facultad de Medicina, Universidad de Chile (División Oriente), Hospital del Salvador.
Revista Medica De Chile
|September 1, 1991
Summary
Sea-blue histiocyte syndrome is a rare genetic disorder causing lipid accumulation. This study details seven cases, highlighting variable prognoses and rare complications like leukemia and lymphoma.
Area of Science:
- Genetics
- Pathology
- Biochemistry
Background:
- Sea-blue histiocyte syndrome (SBHS) is a congenital, hereditary histiolipidosis.
- It resembles Niemann-Pick disease, stemming from an inborn enzymatic error.
Observation:
- Accumulation of oxidized, polymerized lipids, including ceroids, glycophospholipids, and sphingomyelin, is observed.
- These lipids form distinctive blue granules (1-3 µm) in May Grunwald staining.
- Histiocytes are primarily found in bone marrow, liver, and spleen.
Findings:
- Prognosis varies significantly based on affected organs, ranging from fatal CNS involvement to milder spleen/bone marrow cases.
- Potential complications include hepatic cirrhosis and pulmonary fibrosis.
- This paper reports seven cases, four familial, and describes two novel complications: acute myelomonocytic leukemia and histioimmunoblastic lymphoma.
Implications:
- Understanding SBHS pathogenesis is crucial for diagnosis and management.
- Identifying rare complications aids in comprehensive patient care.
- Further research into the specific enzymatic defect could lead to targeted therapies.